Literature DB >> 28371194

Graphene as multifunctional delivery platform in cancer therapy.

Mojgan Nejabat1, Fahimeh Charbgoo2, Mohammad Ramezani2,3.   

Abstract

The biomedical applications of graphene-based nanomaterials including drug and gene delivery have grown rapidly in the past few years. This is due to its high surface area that results in high cargo loading capacity. It is demonstrated that graphene can improve drug efficacy without increasing the dose of the chemotherapeutic agent in cancer treatment. Considering these valuable benefits of graphene, this review focused on the newest advancements in drug and gene delivery systems using graphene and unveiling advantages and disadvantages of different graphene-based materials in introducing an effective cargo delivery system for cancer therapy. Different approaches for reducing cytotoxic impacts of graphene oxide and production of biocompatible delivery platform were also reviewed.
© 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 2355-2367, 2017. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  drug delivery; gene delivery; graphene; graphene oxide; targeting

Mesh:

Substances:

Year:  2017        PMID: 28371194     DOI: 10.1002/jbm.a.36080

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  3 in total

Review 1.  Characteristics of Graphene Oxide for Gene Transfection and Controlled Release in Breast Cancer Cells.

Authors:  Francesca Grilli; Parisa Hajimohammadi Gohari; Shan Zou
Journal:  Int J Mol Sci       Date:  2022-06-18       Impact factor: 6.208

2.  Mechanisms of oxidative stress, apoptosis, and autophagy involved in graphene oxide nanomaterial anti-osteosarcoma effect.

Authors:  Zhibing Tang; Lin Zhao; Zaixing Yang; Zhaohui Liu; Jia Gu; Bing Bai; Jinlian Liu; Jiaying Xu; Huilin Yang
Journal:  Int J Nanomedicine       Date:  2018-05-17

Review 3.  Polymeric Nanoparticles in Cancer Chemotherapy: A Narrative Review.

Authors:  Hossein Ali Yousefi Rizi; Dong Hoon Shin; Shima Yousefi Rizi
Journal:  Iran J Public Health       Date:  2022-02       Impact factor: 1.479

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.